Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Unionman Technology Co.,Ltd.
688609
5
Kingchem
301509
US OptionsDetailed Quotes
GILD250509C100000
- 0.61
- -2.63-81.17%
15min DelayClose May 6 16:00 ET
1.57High0.61Low
1.48Open3.24Pre Close66 Volume4 Open Interest100.00Strike Price6.42KTurnover42.88%IV2.79%PremiumMay 9, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.61Extrinsic Value100Contract SizeAmericanOptions Type0.2957Delta0.0929Gamma143.94Leverage Ratio-0.2420Theta0.0022Rho42.56Eff Leverage0.0299Vega
Gilead Sciences Newsroom
Gilead Sciences Down Nearly 5%, On Track for Largest Percent Decrease Since January 2024 -- Data Talk
Unusual Options Activity: SN, GILD and Others Attract Market Bets, SN V/OI Ratio Reaches 253.5
TD Cowen Maintains Gilead Sciences(GILD.US) With Buy Rating, Maintains Target Price $110
TD Cowen Keeps Their Buy Rating on Gilead Sciences (GILD)
Argus Research Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $120
These Are the Sectors Best Liked Within Defensive and Cyclicals Groups – Morgan Stanley
Express News | Gilead : Mizuho Raises Target Price to $117 From $100
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Gilead and Vertex Pharma Named Among Biotech's Tariff Safe Havens
Mizuho Securities Maintains Gilead Sciences(GILD.US) With Buy Rating, Announces Target Price $117
Gilead Sciences (GILD) Gets a Buy From Mizuho Securities
Wolfe Research Adjusts Gilead Sciences Price Target to $115 From $110
30 U.S. Picks Based on Up Vs. Down EPS Revisions and Dividend Payouts
10 Stocks Defying Wall Street Turbulence to Kick off the Month of May
Gilead Sciences' (NASDAQ:GILD) Performance Is Even Better Than Its Earnings Suggest
Gilead Sciences: Hold Rating Maintained Amid Near-Term Challenges and Limited Growth Prospects
Gilead Sciences to Present at Upcoming Investor Conferences
Gilead Sciences Agrees to Pay $202 Million to Settle Claims of Kickbacks to Doctors for HIV Drug Prescriptions
Express News | U.S. Attorney in Manhattan Announces $202 Mln Settlement With Gilead Sciences for Using Speaker Programs to Pay Kickbacks to Doctors
CIBC Introducing Additional U.S. Canadian Depositary Receipts
Market Insights
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now